doi: 10.5455/ijmsph.2015.24012015174 Soliman AT, De Sanctis V, Yassin M, Wagdy M, Soliman N
Here we show that HGF adopts an enhanced form with dynamically increased receptor-binding affinity and nitration-dysfunction resistance through interaction with lipoic acid trisulfide (LASSS) under physiological conditions
This helps them expand their product lines, especially in obesity and type 2 diabetes
Novel GLP-1R Agonists in Neurotherapeutics NLY01 is a pegylated, long-acting GLP-1 receptor agonist designed with a unique peptide sequence that facilitates blood-brain barrier penetration and sustained brain exposure
The recent rise in GLP-1 receptor agonist prescriptions has resulted in a medication shortage, according to Yee Hui Yeo, MD, MSc, from Cedars-Sinai Medical Center, and colleagues
Tumor-selective catalytic nanomedicine by nanocatalyst delivery